Cargando…

Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study

OBJECTIVE: The most severe complication associated with giant coronary aneurysm in children with Kawasaki disease is ischemic cardiomyopathy (ICM) caused by thrombosis. Addition of tissue plasminogen activator, Alteplase, in the treatment regimen can be an efficient thrombolytic therapy, and therefo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Yanqiu, Xu, Yunming, Wang, Ce, Yu, Xiaona, Ma, Quanmei, Wang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720999/ https://www.ncbi.nlm.nih.gov/pubmed/36471358 http://dx.doi.org/10.1186/s12969-022-00767-7

Ejemplares similares

Ixonnexin from Tick Saliva Promotes Fibrinolysis by Interacting with Plasminogen and Tissue-Type Plasminogen Activator, and Prevents Arterial Thrombosis
por: Assumpção, Teresa C., et al.
Publicado: (2018)

A Neonatal Thrombosis Patient Treated Successfully with Recombinant Tissue Plasminogen Activator
por: Erdinç, Kemal, et al.
Publicado: (2013)

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
por: Imbarrato, Gregory, et al.
Publicado: (2018)

Homocystinuria with Cerebral Venous Sinus Thrombosis: Excellent Recovery with Intravenous Recombinant Tissue Plasminogen Activator
por: Gowda, Vykuntaraju K, et al.
Publicado: (2017)

Mechanical thrombectomy combined with recombinant tissue plasminogen activator thrombolysis in the venous sinus for the treatment of severe cerebral venous sinus thrombosis
por: ZHEN, YONG, et al.
Publicado: (2015)

Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review
por: Chan, Chrystal, et al.
Publicado: (2022)

Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Kunjukunju, Nancy, et al.
Publicado: (2011)

Relationship between tissue plasminogen activator, plasminogen activator inhibitor and CT image in chronic subdural hematoma.
por: Lim, D. J., et al.
Publicado: (1995)

Comparison of KD3-M and KD3-L Multiligamentous Knee Injuries and Analysis of Predictive Factors That Influence the Outcomes of Single-Stage Reconstruction in KD3 Injuries
por: Sundararajan, Silvampatti Ramasamy, et al.
Publicado: (2018)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Tissue-Type Plasminogen Activator-Inhibitor Complex as an Early Predictor of Septic Shock: A Retrospective, Single-Center Study
por: Zhong, Lincui, et al.
Publicado: (2022)

Zinc-Triggered Induction of Tissue Plasminogen Activator and Plasminogen in Endothelial Cells and Pericytes
por: Cho, Mun-Kyung, et al.
Publicado: (2013)

KdV & KAM
por: Kappeler, Thomas, et al.
Publicado: (2003)

Mechanical venous thrombectomy and prolonged infusion of tissue plasminogen activator for cerebral venous sinus thrombosis: Video case report
por: Housley, Steven B., et al.
Publicado: (2020)

Transvenous Catheter-Based Thrombolysis With Continuous Tissue Plasminogen Activator Infusion for Refractory Thrombosis in a Patient With Behcet’s Disease
por: Arif, Saeed, et al.
Publicado: (2020)

Selective Sphingosine 1-Phosphate Receptor 1 Modulation Augments Thrombolysis of Low-Dose Tissue Plasminogen Activator Following Cerebrovascular Thrombosis
por: Li, Han-Dong, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor-1 Potentiates Neutrophil Infiltration and Tissue Injury in Colitis
por: Wang, Xinqiong, et al.
Publicado: (2023)

Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
por: Kim, Hong-Soo, et al.
Publicado: (2003)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Cell type specificity of tissue plasminogen activator in the mouse barrel cortex
por: Chu, Philip, et al.
Publicado: (2015)

Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment
por: Liu, Yonge, et al.
Publicado: (2020)

Ziqi Dihuang decoction ameliorates thrombosis in septic rats by inhitbiting plasminogen activator inhibitor-1
por: Geng, YanXia, et al.
Publicado: (2023)

Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13
por: Fan, Mengchen, et al.
Publicado: (2016)

Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers
por: Aparicio, Hugo J., et al.
Publicado: (2015)

Tissue plasminogen activator for axillary Impella 5.0 with heparin-induced thrombocytopenia as a treatment of choice for acute Impella thrombosis: a case report
por: Merino, Elena, et al.
Publicado: (2023)

Role of Tissue Plasminogen Activator in Loculated Ascites
por: Alkhero, Mohammed, et al.
Publicado: (2021)

Characterization of antibody response against 16kD and 38kD of M. tuberculosis in the assisted diagnosis of active pulmonary tuberculosis
por: Hao, Xiaohui, et al.
Publicado: (2020)

Oviduct-specific expression of tissue plasminogen activator in laying hens
por: Kaleri, Hubdar Ali, et al.
Publicado: (2011)

Lack of durable protection against cotton smoke-induced acute lung injury in sheep by nebulized single chain urokinase plasminogen activator or tissue plasminogen activator
por: Fukuda, Satoshi, et al.
Publicado: (2018)

Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2
Publicado: (1988)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced In Vitro Cerebral Angiogenesis
por: Teng, Hua, et al.
Publicado: (2012)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
por: Jasmiad, Nurbadriah binti, et al.
Publicado: (2022)

The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator
por: Babenko, Valentina A., et al.
Publicado: (2023)

Tissue plasminogen activator-independent roles of neuroserpin in the central nervous system★
por: Ma, Jiao, et al.
Publicado: (2012)

An Endothelial Storage Granule for Tissue-Type Plasminogen Activator
por: Emeis, J.J., et al.
Publicado: (1997)

Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator
por: Hoirisch-Clapauch, Silvia, et al.
Publicado: (2015)

Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
por: Filatov, Asia, et al.
Publicado: (2021)

Roles of the tissue-type plasminogen activator in immune response
por: Seillier, Célia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3anq3i9dav5n1th6u3hobjn10b